<DOC>
	<DOCNO>NCT02192255</DOCNO>
	<brief_summary>This multisite pragmatic clinical trial design assess effectiveness single script telephone call diabetes patient ( ) currently recommend clinical goal glucose , blood pressure , lipid , ( b ) recently prescribe new medication specific clinical domain . The goal intervention improve primary adherence persistence newly prescribe medication improve control glucose , blood pressure , lipid .</brief_summary>
	<brief_title>SUPREME-DM ( Diabetes Mellitis ) Treatment Study</brief_title>
	<detailed_description>This randomized trial test hypothesis telephone contact patient recently prescribe new medication uncontrolled glycated hemoglobin ( A1c ) , blood pressure , low-density lipoprotein cholesterol would improve ( ) primary medication adherence , ( b ) medication persistence , ( c ) medication possession ratio , ( ) A1c , blood pressure low-density lipoprotein cholesterol control . This study part large Agency Healthcare Research Quality fund SUPREME-DM study . The clinical trial report coordinate led HealthPartners Institute Education Research , data collection coordinate Kaiser Permanente Northwest analysis conduct Kaiser Permanente Colorado . The clinical intervention site study include Kaiser Permanente Northern California , Group Health Cooperative , Marshfield Clinic , Geisinger Clinic .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>At clinical intervention site , study subject select : age 1875 year meet study criterion diabetes mellitus study enrollment receive clinical care designate clinic medical center involve study least 15 month enrollment prescribe new class medication ( fill past 180 day ) A1c , BP , LDL uncontrolled time medication prescription ( A1c &gt; =8 % , systolic BP &gt; = 140 mm Hg , LDL &gt; =100 mg/dL ) . Study subject exclude young 18 year age Older 75 year age Did evidence diabetes mellitus prior study enrollment Were receive care clinic site involve study least 15 month enrollment Did prescribe new class medication uncontrolled A1c , BP LDL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>diabetes type 2</keyword>
	<keyword>primary care</keyword>
	<keyword>chronic disease care improvement</keyword>
	<keyword>adherence , randomize trial</keyword>
	<keyword>BP control</keyword>
	<keyword>lipid control</keyword>
	<keyword>glucose control</keyword>
	<keyword>natural language processing .</keyword>
</DOC>